SHARED: An International Collaboration to Unravel Hepatitis C Resistance

Viruses. 2021 Aug 10;13(8):1580. doi: 10.3390/v13081580.

¹ British Columbia Centre for Disease Control, Vancouver, BC V5Z 4R4, Canada.
² Department of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.
³ Department of Internal Medicine 1, University Hospital, Goethe University, 65926 Frankfurt, Germany.
⁴ Erasmus Medical Center, 3015 CN Rotterdam, The Netherlands.
⁵ The Kirby Institute, UNSW Sydney, Sydney, NSW 2006, Australia.
⁶ Department of Pathology, University of New South Wales, Sydney, NSW 2006, Australia.
⁷ Department of Medical Sciences, Clinical Microbiology, Uppsala University, 75121 Uppsala, Sweden.
⁸ Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, NSW 2145, Australia.
⁹ Department of Infectious Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 70-507 Szczecin, Poland.
¹⁰ Department of Medicine, University of British Columbia, Vancouver, BC V5Z 4R4, Canada.
¹¹ National Reference Center for Viral Hepatitis B, C and D, Department of Virology, Henri Mondor Hospital & INSERM U955, 94000 Créteil, France.
¹² Microbiology Department, University Hospital San Cecilio, Instituto de Investigacion Ibs.Granada, 18012 Granada, Spain.

Abstract

The advent of direct-acting antivirals (DAAs) has transformed the treatment landscape of hepatitis C [...].